Abstract:In cases of fetal aortic stenosis and evolving Hypoplastic Left Heart Syndrome (feHLHS), aortic stenosis is associated with specific abnormalities such as retrograde or bidirectional systolic transverse arch flow. Many cases progressed to hypoplastic left heart syndrome (HLHS) malformation at birth, but fetal aortic valvuloplasty can prevent the progression in many cases. Since both disease and intervention involve drastic changes to the biomechanical environment, in-vivo biomechanics likely play a role in… Show more
“… AV – aortic valve; MV – mitral valve; RV – right ventricle; SV – stroke volume; LV – left ventricle; EDV – end-diastolic volume; EF – ejection fraction; MR – mitral regurgitation; AR – aortic regurgitation. Disease cohort data from the current study were combined with pre-FAV and healthy cohort data from Wong et al 35 All data are presented as mean ± standard deviation. † p < 0.05 comparing diseased pre-FAV to healthy and post-FAV to healthy; ‡ p < 0.05 comparing diseased pre-FAV and corresponding post-FAV cases.…”
Section: Resultsmentioning
confidence: 99%
“…Vorticity dynamics were generally quiescent in pre-FAV LVs due to low flow rates, but there was a wide variability from case to case. Figure 2 Flow visualisation at different time points of the cardiac cycle using the lambda2 vortex criterion iso-surfaces and wall shear stress color contour plots for two representative healthy LVs and five FAS LVs pre- and post-FAV with data combined from Wong et al 35 Further results are shown in Supplementary Figure S2 and Supplementary Videos S1–12. …”
Section: Resultsmentioning
confidence: 99%
“…The spatial distributions of time-averaged WSS (TAWSS) and OSI for two age groups (21–22 weeks, 28–31 weeks) are shown for the two representative healthy cases, 35 and two pre-FAV cases and their corresponding post-FAV cases in Fig. 4 .…”
Section: Resultsmentioning
confidence: 99%
“…1 and was described in our previous study, where all model parameters are given. 35 The model was originally proposed by Pennati et al , 21 , 22 but was recalibrated to match more recent human fetal clinical measurements, including fetal abdominal aortic pulse pressures across gestational ages, and systolic and diastolic LV pressure across gestational ages. 9 , 30 Figure 1 Scheme of the human fetal circulation lumped parameter model coupled to the CFD model of the left ventricle, adapted from Pennati et al 21 AA: Ascending aorta, AO1: aortic arch, AO2: thoracic descending aorta, AO3: abdominal descending aorta, AO4: femoral descending aorta, BR: brain, CA: cerebral arteries, HE: liver, INTE: intestinal circulation, IVC: inferior vena cava, KID: kidney, LA: left atrium, LEG: lower limbs, LUNG: lungs, PA1: main pulmonary artery, PA2: pulmonary arteries, PLAC: placenta, RA: right atrium, RV: right ventricle, SVC: superior vena cava, UB: upper body, UV: umbilical vein.…”
Section: Methodsmentioning
confidence: 99%
“…We have previously characterized the fluid mechanics of diseased FAS LV and found altered vorticity dynamics, wall shear stress (WSS) spatial patterns, excessive flow energy losses, and poor turnover of blood. 35 However, a detailed investigation of the biomechanical impact of FAV has not been conducted, and our current understanding of its impact is limited to echocardiographic measurements with limited resolution.…”
Fetuses with critical aortic stenosis (FAS) are at high risk of progression to HLHS by the time of birth (and are thus termed “evolving HLHS”). An in-utero catheter-based intervention, fetal aortic valvuloplasty (FAV), has shown promise as an intervention strategy to circumvent the progression, but its impact on the heart’s biomechanics is not well understood. We performed patient-specific computational fluid dynamic (CFD) simulations based on 4D fetal echocardiography to assess the changes in the fluid mechanical environment in the FAS left ventricle (LV) directly before and 2 days after FAV. Echocardiograms of five FAS cases with technically successful FAV were retrospectively analysed.
FAS compromised LV stroke volume and ejection fraction, but FAV rescued it significantly. Calculations to match simulations to clinical measurements showed that FAV approximately doubled aortic valve orifice area, but it remained much smaller than in healthy hearts. Diseased LVs had mildly stenotic mitral valves, which generated fast and narrow diastolic mitral inflow jet and vortex rings that remained unresolved directly after FAV. FAV further caused aortic valve damage and high-velocity regurgitation. The high-velocity aortic regurgitation jet and vortex ring caused a chaotic flow field upon impinging the apex, which drastically exacerbated the already high energy losses and poor flow energy efficiency of FAS LVs. Two days after the procedure, FAV did not alter wall shear stress (WSS) spatial patterns of diseased LV but elevated WSS magnitudes, and the poor blood turnover in pre-FAV LVs did not significantly improve directly after FAV. FAV improved FAS LV’s flow function, but it also led to highly chaotic flow patterns and excessively high energy losses due to the introduction of aortic regurgitation directly after the intervention. Further studies analysing the effects several weeks after FAV are needed to understand the effects of such biomechanics on morphological development.
“… AV – aortic valve; MV – mitral valve; RV – right ventricle; SV – stroke volume; LV – left ventricle; EDV – end-diastolic volume; EF – ejection fraction; MR – mitral regurgitation; AR – aortic regurgitation. Disease cohort data from the current study were combined with pre-FAV and healthy cohort data from Wong et al 35 All data are presented as mean ± standard deviation. † p < 0.05 comparing diseased pre-FAV to healthy and post-FAV to healthy; ‡ p < 0.05 comparing diseased pre-FAV and corresponding post-FAV cases.…”
Section: Resultsmentioning
confidence: 99%
“…Vorticity dynamics were generally quiescent in pre-FAV LVs due to low flow rates, but there was a wide variability from case to case. Figure 2 Flow visualisation at different time points of the cardiac cycle using the lambda2 vortex criterion iso-surfaces and wall shear stress color contour plots for two representative healthy LVs and five FAS LVs pre- and post-FAV with data combined from Wong et al 35 Further results are shown in Supplementary Figure S2 and Supplementary Videos S1–12. …”
Section: Resultsmentioning
confidence: 99%
“…The spatial distributions of time-averaged WSS (TAWSS) and OSI for two age groups (21–22 weeks, 28–31 weeks) are shown for the two representative healthy cases, 35 and two pre-FAV cases and their corresponding post-FAV cases in Fig. 4 .…”
Section: Resultsmentioning
confidence: 99%
“…1 and was described in our previous study, where all model parameters are given. 35 The model was originally proposed by Pennati et al , 21 , 22 but was recalibrated to match more recent human fetal clinical measurements, including fetal abdominal aortic pulse pressures across gestational ages, and systolic and diastolic LV pressure across gestational ages. 9 , 30 Figure 1 Scheme of the human fetal circulation lumped parameter model coupled to the CFD model of the left ventricle, adapted from Pennati et al 21 AA: Ascending aorta, AO1: aortic arch, AO2: thoracic descending aorta, AO3: abdominal descending aorta, AO4: femoral descending aorta, BR: brain, CA: cerebral arteries, HE: liver, INTE: intestinal circulation, IVC: inferior vena cava, KID: kidney, LA: left atrium, LEG: lower limbs, LUNG: lungs, PA1: main pulmonary artery, PA2: pulmonary arteries, PLAC: placenta, RA: right atrium, RV: right ventricle, SVC: superior vena cava, UB: upper body, UV: umbilical vein.…”
Section: Methodsmentioning
confidence: 99%
“…We have previously characterized the fluid mechanics of diseased FAS LV and found altered vorticity dynamics, wall shear stress (WSS) spatial patterns, excessive flow energy losses, and poor turnover of blood. 35 However, a detailed investigation of the biomechanical impact of FAV has not been conducted, and our current understanding of its impact is limited to echocardiographic measurements with limited resolution.…”
Fetuses with critical aortic stenosis (FAS) are at high risk of progression to HLHS by the time of birth (and are thus termed “evolving HLHS”). An in-utero catheter-based intervention, fetal aortic valvuloplasty (FAV), has shown promise as an intervention strategy to circumvent the progression, but its impact on the heart’s biomechanics is not well understood. We performed patient-specific computational fluid dynamic (CFD) simulations based on 4D fetal echocardiography to assess the changes in the fluid mechanical environment in the FAS left ventricle (LV) directly before and 2 days after FAV. Echocardiograms of five FAS cases with technically successful FAV were retrospectively analysed.
FAS compromised LV stroke volume and ejection fraction, but FAV rescued it significantly. Calculations to match simulations to clinical measurements showed that FAV approximately doubled aortic valve orifice area, but it remained much smaller than in healthy hearts. Diseased LVs had mildly stenotic mitral valves, which generated fast and narrow diastolic mitral inflow jet and vortex rings that remained unresolved directly after FAV. FAV further caused aortic valve damage and high-velocity regurgitation. The high-velocity aortic regurgitation jet and vortex ring caused a chaotic flow field upon impinging the apex, which drastically exacerbated the already high energy losses and poor flow energy efficiency of FAS LVs. Two days after the procedure, FAV did not alter wall shear stress (WSS) spatial patterns of diseased LV but elevated WSS magnitudes, and the poor blood turnover in pre-FAV LVs did not significantly improve directly after FAV. FAV improved FAS LV’s flow function, but it also led to highly chaotic flow patterns and excessively high energy losses due to the introduction of aortic regurgitation directly after the intervention. Further studies analysing the effects several weeks after FAV are needed to understand the effects of such biomechanics on morphological development.
Fetal critical aortic stenosis with evolving hypoplastic left heart syndrome (CAS-eHLHS) can progress to a univentricular (UV) birth malformation. Catheter-based fetal aortic valvuloplasty (FAV) can resolve stenosis and reduce the likelihood of malformation progression. However, we have limited understanding of the biomechanical impact of FAV and subsequent LV responses. Therefore, we performed image-based finite element (FE) modeling of 4 CAS-eHLHS fetal hearts, by performing iterative simulations to match image-based characteristics and then back-computing physiological parameters. We used pre-FAV simulations to conduct virtual FAV (vFAV) and compared pre-FAV and post-FAV simulations. vFAV simulations generally enabled partial restoration of several physiological features toward healthy levels, including increased stroke volume and myocardial strains, reduced aortic valve (AV) and mitral valve regurgitation (MVr) velocities, reduced LV and LA pressures, and reduced peak myofiber stress. FAV often leads to aortic valve regurgitation (AVr). Our simulations showed that AVr could compromise LV and LA depressurization but it could also significantly increase stroke volume and myocardial deformational stimuli. Post-FAV scans and simulations showed FAV enabled only partial reduction of the AV dissipative coefficient. Furthermore, LV contractility and peripheral vascular resistance could change in response to FAV, preventing decreases in AV velocity and LV pressure, compared with what would be anticipated from stenosis relief. This suggested that case-specific post-FAV modeling is required to fully capture cardiac functionality. Overall, image-based FE modeling could provide mechanistic details of the effects of FAV, but computational prediction of acute outcomes was difficult due to a patient-dependent physiological response to FAV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.